Literature DB >> 17548394

Noncompliance in randomized controlled trials.

Jeevan P Marasinghe, A A W Amarasinghe.   

Abstract

Mesh：

Year:  2007        PMID： 17548394      PMCID： PMC1877838          DOI： 10.1503/cmaj.1060189

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Is there another way to take account of noncompliance in randomized controlled trials?

Authors:  Catherine E Hewitt; David J Torgerson; Jeremy N V Miles
Journal:  CMAJ       Date:  2006-08-15       Impact factor: 8.262

Review 2.  The effect of partial noncompliance on the power of a clinical trial.

Authors:  L S Freedman
Journal:  Control Clin Trials       Date:  1990-06

3.  Efficacy of rivastigmine on activities of daily living in Sri Lankan patients with Alzheimer disease and on improving caregiver burden: a prospective study.

Authors:  H A de Silva; A Pathmeswaran; S B Gunatilake
Journal:  Ceylon Med J       Date:  2005-09

Review 4.  Incorporating patient preferences into randomized trials.

Authors:  M F Lambert; J Wood
Journal:  J Clin Epidemiol       Date:  2000-02       Impact factor: 6.437

5.  Informative noncompliance in endpoint trials.

Authors:  Steven M Snapinn; Qi Jiang; Boris Iglewicz
Journal:  Curr Control Trials Cardiovasc Med       Date:  2004-07-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.